ArticleBiotechnology for biofuels and bioproducts2025
Preliminary Evaluation of lutein and zeaxanthin variability in DDGS from corn ethanol facilities.
Article in Biotechnology for biofuels and bioproducts, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Navigating the unpredictable nature of feedstock is crucial in bioprocessing. Manufacturing designs for homogeneous inputs to produce high-quality outputs, but biomass is inherently inconsistent. In bioethanol production, ethanol yield can depend on the type of corn itself in addition to the processing conditions to which it is subjected. While bioethanol processing adheres to standard operating conditions, there remains variability between facilities, an important point when considering the bioethanol byproduct DDGS as a commercial source for lutein and zeaxanthin extraction. Lutein and zeaxanthin are derived commercially from marigold flowers, which is chemically intensive and prohibits new players from entering the market. Exploring the potential of DDGS as a source of lutein and zeaxanthin would incentivize both corn growers and biorefineries but requires characterizing the differences in the yield potential of DDGS from separate bioethanol facilities. In this study, defatted DDGS from five Midwestern bioethanol facilities were examined using Soxhlet extraction with ethanol and subsequent HPLC analysis for lutein and zeaxanthin content. Using nonparametric methods and α = 0.05, it was determined that although facility appeared to have a significant effect on zeaxanthin yield, lutein yield displayed a greater degree of variability and differences in zeaxanthin yield could not be statistically ascribed to facility. Ultimately, the variability in corn growth and harvest and the downstream processing are too great to fully attribute any differences to facility alone. Future studies should consider sampling intermediate products throughout the biorefining process, as well as analyzing the incoming corn directly and comparing it to the final defatted DDGS to more fully understand how lutein and zeaxanthin partition and/or degrade during processing for a single variety of corn.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.